Nicolas Skuli

3.7k total citations
45 papers, 2.6k citations indexed

About

Nicolas Skuli is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Nicolas Skuli has authored 45 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Cancer Research and 8 papers in Genetics. Recurrent topics in Nicolas Skuli's work include Cancer, Hypoxia, and Metabolism (17 papers), Glioma Diagnosis and Treatment (8 papers) and Epigenetics and DNA Methylation (5 papers). Nicolas Skuli is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Glioma Diagnosis and Treatment (8 papers) and Epigenetics and DNA Methylation (5 papers). Nicolas Skuli collaborates with scholars based in United States, France and Slovakia. Nicolas Skuli's co-authors include M. Celeste Simon, Romain Riscal, Brian Keith, Christine Toulas, Sylvie Monferran, Guoliang Qing, John M. Maris, Patrick A. Mayes, Caroline Delmas and Gilles Favre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Nicolas Skuli

44 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Skuli United States 28 1.6k 1.3k 444 298 278 45 2.6k
Theresa LaVallee United States 22 1.4k 0.9× 745 0.6× 722 1.6× 239 0.8× 275 1.0× 57 2.4k
Nabendu Pore United States 17 1.4k 0.9× 1.1k 0.8× 614 1.4× 101 0.3× 287 1.0× 26 2.3k
Antonella Papa United States 18 2.4k 1.5× 560 0.4× 855 1.9× 193 0.6× 390 1.4× 29 3.1k
Levi J. Beverly United States 28 1.7k 1.1× 403 0.3× 601 1.4× 277 0.9× 163 0.6× 65 2.7k
Ichiro Nakano United States 28 1.9k 1.2× 738 0.6× 798 1.8× 175 0.6× 165 0.6× 34 2.8k
Fabrizio Bianchi Italy 32 1.8k 1.1× 1.2k 0.9× 853 1.9× 361 1.2× 642 2.3× 87 3.1k
Naoharu Takano Japan 23 1.3k 0.8× 978 0.8× 595 1.3× 182 0.6× 159 0.6× 45 2.5k
Sajani S. Lakka United States 33 1.7k 1.1× 1.4k 1.1× 860 1.9× 195 0.7× 209 0.8× 56 3.0k
Irene Newsham United States 29 1.5k 1.0× 469 0.4× 368 0.8× 228 0.8× 309 1.1× 44 2.8k
Robert Winqvist Finland 34 2.1k 1.3× 853 0.7× 936 2.1× 196 0.7× 273 1.0× 89 3.3k

Countries citing papers authored by Nicolas Skuli

Since Specialization
Citations

This map shows the geographic impact of Nicolas Skuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Skuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Skuli more than expected).

Fields of papers citing papers by Nicolas Skuli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Skuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Skuli. The network helps show where Nicolas Skuli may publish in the future.

Co-authorship network of co-authors of Nicolas Skuli

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Skuli. A scholar is included among the top collaborators of Nicolas Skuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Skuli. Nicolas Skuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuller, Ashley M., Valerie Irizarry-Negron, Ann Devine, et al.. (2024). Sarcoma Cells Secrete Hypoxia-Modified Collagen VI to Weaken the Lung Endothelial Barrier and Promote Metastasis. Cancer Research. 84(7). 977–993. 8 indexed citations
2.
Riscal, Romain, Sarah M. Gardner, Nathan J. Coffey, et al.. (2024). Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma. Cancer Research. 84(10). 1570–1582. 9 indexed citations
3.
Willis, Elinor, Esha Banerjee, Charles‐Antoine Assenmacher, et al.. (2023). 22 Humanized NOG-EXL mice exhibit improved overall survival and less severe myeloid cell activation relative to humanized NSG-SGM3 mice. SHILAP Revista de lepidopterología. A24–A24.
4.
Skuli, Sarah, et al.. (2022). Metformin and Cancer, an Ambiguanidous Relationship. Pharmaceuticals. 15(5). 626–626. 35 indexed citations
5.
Godfrey, Jason T., Romain Riscal, Nicolas Skuli, & M. Celeste Simon. (2022). Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells. SHILAP Revista de lepidopterología. 10(1). 4–4. 3 indexed citations
6.
Sanchez, Danielle J., Rindert Missiaen, Nicolas Skuli, David J. Steger, & M. Celeste Simon. (2021). Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma. Molecular Cancer Research. 19(4). 598–611. 9 indexed citations
7.
Anderson, Nicole, Xiaodan Qin, Jennifer M. Finan, et al.. (2021). Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma. Cancer Research. 81(17). 4417–4430. 44 indexed citations
8.
Smith, Stuart, Betty Tyler, Gareth J. Veal, et al.. (2019). Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste. Clinical Cancer Research. 25(16). 5094–5106. 40 indexed citations
9.
Bansal, Ankita, et al.. (2019). Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression. Molecular Cancer Research. 17(9). 1881–1892. 35 indexed citations
10.
Sanchez, Danielle J., David J. Steger, Nicolas Skuli, Ankita Bansal, & M. Celeste Simon. (2018). PPARγ is dispensable for clear cell renal cell carcinoma progression. Molecular Metabolism. 14. 139–149. 17 indexed citations
11.
Lin, Nan, Jessica E.S. Shay, Hong Xie, et al.. (2018). Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis. Frontiers in Immunology. 9. 2565–2565. 29 indexed citations
12.
Bras, Morgane Le, Nicolas Skuli, Sébastien Britton, et al.. (2016). A novel cytoprotective function for the DNA repair protein Ku in regulating p53 mRNA translation and function. EMBO Reports. 17(4). 508–518. 25 indexed citations
13.
Krock, Bryan L., T.S. Karin Eisinger‐Mathason, Jessica E.S. Shay, et al.. (2015). The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability. Blood. 125(21). 3263–3272. 35 indexed citations
14.
Shay, Jessica E.S., Hongxia Z. Imtiyaz, Sharanya Sivanand, et al.. (2014). Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer. Carcinogenesis. 35(5). 1067–1077. 57 indexed citations
15.
Buonato, Janine M., Nicolas Skuli, Lijoy K. Mathew, et al.. (2014). Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells. Journal of Cell Science. 127(Pt 16). 3555–67. 42 indexed citations
16.
Eisinger‐Mathason, T.S. Karin, Minsi Zhang, Qiong Qiu, et al.. (2013). Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis. Cancer Discovery. 3(10). 1190–1205. 213 indexed citations
17.
Mathew, Lijoy K., Samuel S. Lee, Nicolas Skuli, et al.. (2013). Restricted Expression of miR-30c-2-3p and miR-30a-3p in Clear Cell Renal Cell Carcinomas Enhances HIF2α Activity. Cancer Discovery. 4(1). 53–60. 68 indexed citations
18.
Qing, Guoliang, Nicolas Skuli, Patrick A. Mayes, et al.. (2010). Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1α. Cancer Research. 70(24). 10351–10361. 128 indexed citations
19.
Skuli, Nicolas, Sylvie Monferran, Caroline Delmas, et al.. (2009). αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma. Cancer Research. 69(8). 3308–3316. 107 indexed citations
20.
Skuli, Nicolas, Liping Liu, Anja Runge, et al.. (2009). Endothelial deletion of hypoxia-inducible factor–2α (HIF-2α) alters vascular function and tumor angiogenesis. Blood. 114(2). 469–477. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa LaVallee Breakdown of academic impact, for papers by Nabendu Pore Breakdown of academic impact, for papers by Antonella Papa Breakdown of academic impact, for papers by Levi J. Beverly Breakdown of academic impact, for papers by Ichiro Nakano Breakdown of academic impact, for papers by Fabrizio Bianchi Breakdown of academic impact, for papers by Naoharu Takano Breakdown of academic impact, for papers by Sajani S. Lakka Breakdown of academic impact, for papers by Irene Newsham Breakdown of academic impact, for papers by Robert Winqvist
Rankless by CCL
2026